| Literature DB >> 21512418 |
Priya Rajagopalan1, Xue Hua, Arthur W Toga, Clifford R Jack, Michael W Weiner, Paul M Thompson.
Abstract
Elevated homocysteine levels are a known risk factor for Alzheimer's disease and vascular disorders. Here we applied tensor-based morphometry to brain magnetic resonance imaging scans of 732 elderly individuals from the Alzheimer's Disease Neuroimaging Initiative study, to determine associations between homocysteine and brain atrophy. Those with higher homocysteine levels showed greater frontal, parietal, and occipital white matter atrophy in the entire cohort, irrespective of diagnosis, age, or sex. This association was also found when considering mild cognitive impairment individuals separately. Vitamin B supplements, such as folate, may help prevent homocysteine-related atrophy in Alzheimer's disease by possibly reducing homocysteine levels. These atrophy profiles may, in the future, offer a potential biomarker to gauge the efficacy of interventions using dietary folate supplementation.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21512418 PMCID: PMC3192851 DOI: 10.1097/WNR.0b013e328346bf85
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837